Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer

Niamh McGivern(Queen's University Belfast), Nuala McCabe(Queen's University Belfast)
Oncotarget
December 20, 2017
Cited by 32


Related Papers

No related papers found

Powered by citation graph analysis